Consistently, the dysregulation of the latter is associated with an immunomodulatory response in DCM; in contrast, NLRP3 silencing improves cardiac remodeling in diabetes and alters cardiac function [17]. This evidence concerns the gene NLRP3 and familial dilated cardiomyopathy.